Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Błażej Łyszczarz has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Excess life-years and productive life-years lost in Poland through the COVID-19 pandemic and post-pandemic years

    by Błażej Łyszczarz, Jakub Wojtasik, Tomasz Zieliński

    Background: Poland’s COVID-19 experience resulted in one of Europe’s most severe mortality shocks, yet the share of lost life-years occurring at working age has not been quantified. Methods: We analysed weekly all-cause deaths by sex and 5-year age groups for 2011–2019, and fitted fixed effects linear models to forecast expected mortality rates for 2020–2024. Next, we compared predicted and observed rates to estimate excess mortality. These estimates were converted into excess deaths and p-scores, excess Years of Potential Life Lost (eYPLL) and excess Years of Potential Productive Life Lost (eYPPLL). Results: We estimated 257,246 excess deaths in Poland over the five-year horizon (13.4% and 12.2% more deaths than expected in men and women, respectively). These deaths yielded 1,921,265 eYPLL and 521,887 eYPPLL, meaning that 27% of all life-years lost fell within working age. Men accounted for 54% of excess deaths but 72% of eYPLL and 79% of eYPPLL. More than half of the female and more than a third of the male productive-life loss accrued between ages 30 and 49. Temporal concentration was marked, 46% of excess deaths and 40% of eYPPLL occurred in 2021 alone. In 2023–2024, negative excess mortality emerged among older adults (aged 55–69), but without fully offsetting losses among the working-age and 70 + population. This translated to negative eYPLL in women in 2024, but persistent productive-age losses were still identified in this group. COVID-19-coded fatalities explained almost two-thirds of eYPLL and 40% of eYPPLL during 2020–2024. Poland’s excess mortality resulted in an average loss of 14–15 productive years for every excess death before retirement. Conclusions: This study extends usual excess deaths estimates to the productive life lost dimension and shows that the pandemic curtailed not only longevity but also burdened Poland with over half a million labour-force years lost. These losses magnify pre-pandemic labour shortages and add demographic pressure, translating to reduced labour supply and potential output, and underscoring the macroeconomic cost of major health shocks such as the COVID-19 pandemic.


  • Open Access

    Excess and reduced work absence during COVID-19 in Poland: insights from cause-specific time-series models

    by Błażej Łyszczarz, Jakub Wojtasik

    Background: The COVID-19 pandemic profoundly disrupted workplace attendance, yet its impact on cause-specific work absence remains largely unexplored. Aim: To estimate the cause-specific excess/reduced work absence associated with COVID-19 in Poland. Methods: Following the concept of excess mortality, we define excess work absence as the difference between observed and expected absence, where the latter reflects the level anticipated in the absence of the pandemic. Using time-series analysis (Seasonal Autoregressive Integrated Moving Average) on pre-pandemic (2012–2019) quarterly (Q) social insurance data, we forecasted absence rates for disease groups (classified by ICD-10 chapters) and caregiving-related absenteeism. Forecasted absence rates were then compared to observed values during 2020–2024, allowing for the identification of excess or reduced work absence. Results: We observed notable deviations in work absence rates during the pandemic period (until the end of Q1-2022). The highest excess absence was identified in caregiving-related absenteeism at the pandemic’s onset, exceeding expected levels by over fivefold. A mental health crisis that began with the pandemic resulted in four consecutive quarters of excess absence, reaching a 54% excess in Q2-2020. We identified a notable excess absence in three ICD-10 chapters that reflect the indirect effects of the pandemic, such as increased diagnostic uncertainty, modified coding practices during early COVID-19 waves, and widespread implementation of public health interventions. Absence rates were lower than expected in neoplasms, endocrine and digestive diseases until the end of the pandemic period, likely reflecting reduced healthcare accessibility. Similarly, absence related to injuries and poisoning was below the expected level until mid-2022, indicating decreased social mobility. Conclusions: COVID-19 substantially reshaped work absence patterns in Poland, particularly during the early pandemic phase. Pronounced increases and decreases were identified across disease categories. These diverging trends plausibly reflect both the COVID-19’s effects on the development of other conditions and disruptions in healthcare access. These findings highlight the need for disease-specific policy responses to mitigate future health crises and ensure continuity of care during pandemics.


  • Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide

    by Paweł Niewiadomski, Marta Ortega-Ortega, Błażej Łyszczarz

    Aim To systematically review the evidence on productivity losses due to health problems arising from the COVID-19 pandemic based on evidence from population-level studies. Methods Following PRISMA statement, we conducted a systematic review using Medline, Embase, Scopus, Web of Science, EconLit, WHO COVID-19 Research and EuropePMC databases and a grey literature search. We included population-level studies using secondary data and qualitatively assessed eligible studies. For a quantitative cross-study comparison, we calculated losses in 2020 international dollars and as a share of gross domestic product. PROSPERO registration number: CRD42023478059. Results Thirty-eight studies were eligible for review, most of which reported losses in high-income countries and the European region. COVID-19 was a focus of 33 studies while 3 studies investigated losses from both long COVID and excess mortality. The Human Capital Approach dominated (30 studies) and no study used the Friction Cost Approach. Most studies (84%) reported on premature mortality losses and a quarter provided estimates of losses due to absenteeism. Of the 33 studies eligible for quantitative comparison, we found that the productivity losses ranged from 0 to 2.1% of gross domestic product; the greatest losses were in the high-income countries and for those aged 40–59 years; and losses among men contributed to around 3/4 of the total burden. Conclusion The available evidence on the topic is limited, particularly considering the methodological approaches used. Thus, more research is needed to reach a more comprehensive understanding of economy-level productivity losses resulting from the recent COVID-19 pandemic.


  • Open Access

    Magnitude and determinants of excess total, age-specific and sex-specific all-cause mortality in 24 countries worldwide during 2020 and 2021: results on the impact of the COVID-19 pandemic from the C-MOR project

    by Chryso Th. Pallari, Souzana Achilleos, Annalisa Quattrocchi, John Gabel, Elena Critselis, Maria Athanasiadou, Mohammad Reza Rahmanian Haghighi, Stefania Papatheodorou, Tianyu Liu, Andreas Artemiou, et al.

    Introduction To examine the impact of the COVID-19 pandemic on mortality, we estimated excess all-cause mortality in 24 countries for 2020 and 2021, overall and stratified by sex and age. Methods Total, age-specific and sex-specific weekly all-cause mortality was collected for 2015–2021 and excess mortality for 2020 and 2021 was calculated by comparing weekly 2020 and 2021 age-standardised mortality rates against expected mortality, estimated based on historical data (2015–2019), accounting for seasonality, and long-term and short-term trends. Age-specific weekly excess mortality was similarly calculated using crude mortality rates. The association of country and pandemic-related variables with excess mortality was investigated using simple and multilevel regression models. Results Excess cumulative mortality for both 2020 and 2021 was found in Austria, Brazil, Belgium, Cyprus, England and Wales, Estonia, France, Georgia, Greece, Israel, Italy, Kazakhstan, Mauritius, Northern Ireland, Norway, Peru, Poland, Slovenia, Spain, Sweden, Ukraine, and the USA. Australia and Denmark experienced excess mortality only in 2021. Mauritius demonstrated a statistically significant decrease in all-cause mortality during both years. Weekly incidence of COVID-19 was significantly positively associated with excess mortality for both years, but the positive association was attenuated in 2021 as percentage of the population fully vaccinated increased. Stringency index of control measures was positively and negatively associated with excess mortality in 2020 and 2021, respectively. Conclusion This study provides evidence of substantial excess mortality in most countries investigated during the first 2 years of the pandemic and suggests that COVID-19 incidence, stringency of control measures and vaccination rates interacted in determining the magnitude of excess mortality.


  • Open Access

    Productivity losses from short-term work absence due to neoplasms in Poland

    by Błażej Łyszczarz

    Previous evidence on productivity losses from neoplasms focuses mostly on the economic burden from mortality, covers single cancer diagnoses and neglects non-malignant neoplasms. This study aims to broaden this perspective by analysing losses resulting from work absence and all neoplasm diagnoses. The analysis applies the human capital method and social insurance data to estimate productivity losses attributable to neoplasm-related short-term work absence in Poland in the period 2012–2022. The productivity losses due to work absence attributable to all neoplasms in Poland were €583 million in 2012 (0.143% of gross domestic product) and they increased to €969 million in 2022 (0.164%). Around 60% of the losses were associated with cancers while the remaining part of the burden was due to non-malignant neoplasms. The neoplasms that led to the highest losses were benign neoplasms, breast cancer, colorectum cancer and prostate cancer. The cancer sites characterised by the greatest losses per absence episode were brain cancer, lung cancer and oesophageal cancer. For most of the neoplasms, we observed increasing losses in an 11-year period analysed. Investing in effective public health policies that tackle neoplasms has the potential to reduce both the health burden and economic losses resulting from these diseases.


  • Open Access

    Incidence and cost of COVID-19-related work absence based on social insurance data from Poland

    by B Łyszczarz

    Background: COVID-19 pandemic and public health measures aimed at limiting the spread of the disease caused widespread work absence. This research aimed to identify the incidence of COVID-19-related short-term work absence and to estimate the cost associated with this absence. Methods: The study used quarterly (Q) social insurance data from Poland (2020-2022). COVID-19-related absence was identified with four ICD-10 classification diagnoses: COVID-19; personal history of COVID-19; post-COVID-19 condition; and multisystem inflammatory syndrome associated with COVID-19. To identify work absence, the study relied on real-life, disease-specific data on the number of absence days from the Social Insurance Institution. Additionally, excess caregiving resulting from the pandemic was estimated based on all-cause caregiving days. To estimate the cost of work absence, the study relied on the human capital method. Results: There were 15.2 million absence days resulting from four COVID-19-related diagnoses (2.1% of total all-cause absence days). Of these, COVID-19 caused 12.2 million absence days, followed by post-COVID-19 condition (2.9 million). Excess caregiving was a dominant pandemic-related work absence category, with 37.7 million work days lost. COVID-19 absence was concentrated in Q4-2020 and high in Q1-2021 and Q3-2022. On the other hand, the incidence of the remaining three diagnoses was the highest in Q1-2022. The total indirect cost of work absence was €4.3 billion, and 69.2% of this loss resulted from excess caregiving. For this cost category, 79.1% of costs were borne in Q2- and Q3-2020 when severe lockdowns were imposed. Conclusions: The estimates show that COVID-19-related short-term absenteeism was a significant public health burden and translated to severe economic losses. The economic loss from caregiving resulted in more burden than the COVID-19 health-related absence. Key messages: • There were 52.9 million work absence days from the COVID-19 pandemic in Poland until the end of 2022, resulting in an indirect cost of €4.3 billion. • Most (∼70%) of the pandemic work absence and its cost resulted from caregiving responsibilities, which applied to care for the sick and children unable to attend educational facilities.


  • Open Access

    Factors Associated with Out-of-Pocket Health Expenditure in Polish Regions

    by Błażej Łyszczarz, Zhaleh Abdi

    Out-of-pocket (OOP) payments are perceived as the most regressive means of health financing. Using the panel-data approach and region-aggregated data from Statistics Poland, this research investigated associations between socio-economic factors and OOP health spending in 16 Polish regions for the period 1999–2019. The dependent variable was real (inflation-adjusted) monthly OOP health expenditure per person in Polish households. Potential independent variables included economic, labour, demographic, educational, health, environmental, and lifestyle measures based on previous research. A set of panel-data estimators was used in regression models. The factors that were positively associated with OOP health spending were disposable income, the proportions of children (aged 0–9) and elderly (70+ years) in the population, healthcare supply (proxied by physicians’ density), air pollution, and tobacco and alcohol expenditure. On the other hand, the increased unemployment rate, life expectancy at age 65, mortality rate, and higher sports participation were all related to lower OOP health spending. The results may guide national strategies to improve health-care allocations and offer additional financial protection for vulnerable groups, such as households with children and elderly members.


  • Open Access

    Production losses due to mortality associated with modifiable health risk factors in Poland

    by Błażej Łyszczarz, Karolina Sowa

    Background: Epidemiological burden of modifiable mortality risk factors is recognized in literature; however, less is known on the economic losses due to a range of such risks. Aim: To estimate production losses (indirect cost) of mortality associated with risk factors as classified in Global Burden of Disease 2019 Study in Poland in years 2000, 2010, and 2017. Methods: We relied on the human capital method and societal perspective and used sex-, age-, region-, and risk-specific data on mortality due to modifiable risk factors and a set of socio-economic measures. Results: The production losses due to mortality attributable to all investigated risk factors accounted for 19.6–21.0 billion PLN (Polish zloty; 2017 exchange rate: 1€ = 4.26 PLN) and 1.44–2.45% of gross domestic product, depending on year. Behavioural factors were the most important contributor to overall burden (16.7–18.2 billion PLN), followed by metabolic factors (6.8–7.6 billion PLN) and environmental and occupational factors (3.0–3.5 billion PLN). Of disaggregated risks, alcohol and tobacco, high systolic blood pressure, and dietary risks proved to lead to the highest losses. Cost per death was greatest for child and maternal malnutrition, followed by intimate partner violence and childhood sexual abuse and bullying. Moreover, a notable regional variation of indirect cost was identified with losses ranging from 1.21 to 1.81% of regional gross domestic product in 2017. Conclusion: Our findings provide economically hierarchised list of modifiable risk factors and they contribute to inform policy-makers in prioritizing programmes to improve health.